サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1579845

医療用外骨格の世界市場

Medical Exoskeleton

出版日
ページ情報
英文 89 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
医療用外骨格の世界市場
出版日: 2024年10月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 89 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療用外骨格の世界市場は2030年までに65億米ドルに到達

2023年に15億米ドルと推定される医療用外骨格の世界市場は、分析期間2023-2030年にCAGR 23.1%で成長し、2030年には65億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるハードウェアコンポーネント（HardwareComponent）は、CAGR 20.2％を記録し、分析期間終了時には32億米ドルに達すると予測されます。ソフトウェアコンポーネント分野の成長率は、分析期間のCAGRで26.4％と推定されます。

米国市場は4億3,560万米ドルと推定、中国はCAGR 21.2％で成長予測

米国の医療用外骨格市場は、2023年に4億3,560万米ドルと推定されます。世界第2位の経済大国である中国は、2023～2030年のCAGR21.2%で推移し、2030年には9億1,410万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ19.6%と19.1%と予測されています。欧州では、ドイツがCAGR約13.4%で成長すると予測されています。

世界の医療用外骨格市場- 主要動向と促進要因まとめ

医療用外骨格はヘルスケアにおけるモビリティをどのように再定義しているか？

医療用外骨格は、脊髄損傷から回復した人や多発性硬化症や脳卒中などの疾患を患っている人など、移動に障害のある人に動力によるサポートを提供するウェアラブルデバイスです。これらのデバイスは、ユーザーの歩行、起立、さらにはリハビリテーション運動の実行を補助し、生活の質を大幅に向上させます。医療用外骨格は、回復を促進し、運動能力を回復させるために使用されるリハビリテーション・センターや病院での採用が増加しています。身体的補助を強化することで、外骨格は患者の自立を可能にし、介護者やヘルスケア専門家の負担を軽減しています。

どのようなイノベーションが医療用外骨格市場を形成しているか？

医療用外骨格におけるイノベーションには、ロボット工学、軽量素材、AI駆動型運動制御システムの進歩が含まれます。これらの開発により、より直感的で応答性の高い外骨格が実現され、よりスムーズで自然な動きが可能となっています。AIの統合により、外骨格はユーザーの動きから学習し、リアルタイムで調整することができるようになり、長期的なリハビリテーションにより効果的なものとなっています。さらに、カーボンファイバーや先端ポリマーなどの新素材のおかげで、外骨格は軽量化し、装着感も向上しています。バッテリー技術も向上しており、頻繁な充電を必要とせずに外骨格を長期間使用できるようになっています。

市場セグメンテーションは医療用外骨格の成長をどのように定義するか？

種類には、動力式外骨格と受動式外骨格があり、動力式外骨格は、より大きな移動支援を提供できることから、最大のシェアを占めています。用途は、リハビリテーションから日常生活用補助装置まで多岐にわたるが、リハビリテーションは、これらの装置が理学療法で広く使用されていることから、主要なセグメントとなっています。エンドユーザーには、病院、リハビリセンター、在宅介護の現場が含まれ、病院とリハビリセンターが支配的な分野です。地理的には、北米が市場をリードし、欧州がこれに続くが、アジア太平洋はヘルスケア技術への投資の増加により急成長しています。

医療用外骨格市場の成長を促進する要因は？

医療用外骨格市場の成長は、神経障害や運動障害の有病率の増加、ロボット工学やAIの進歩、リハビリテーション技術に対する需要の高まりなど、いくつかの要因によってもたらされます。世界人口の高齢化に伴い、移動障害の発生率が上昇しており、外骨格のような支援技術に対する需要が高まっています。ロボット工学と動作制御システムの進歩は、これらのデバイスをより効果的で利用しやすくし、市場の成長をさらに後押ししています。さらに、リハビリテーションを通じて患者の予後を改善することへの注目の高まりや、医療用外骨格に対する保険適用の可能性が高まっていることも、市場の拡大に寄与しています。

調査対象企業の例（全34件）

  • Bionik Laboratories Corp
  • B-TEMIA Inc.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • ExoAtlet
  • Gogoa Mobility Robots SL
  • Hocoma AG（A Subsidiary of DIH Technologies）
  • Parker Hannifin Corp
  • ReWalk Robotics Ltd
  • Rex Bionics Ltd.
  • Tyromotion GmbH
  • US Bionics
  • Wearable Robotics SRL

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP22233

Global Medical Exoskeleton Market to Reach US$6.5 Billion by 2030

The global market for Medical Exoskeleton estimated at US$1.5 Billion in the year 2023, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 23.1% over the analysis period 2023-2030. HardwareComponent, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$3.2 Billion by the end of the analysis period. Growth in the Software Component segment is estimated at 26.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$435.6 Million While China is Forecast to Grow at 21.2% CAGR

The Medical Exoskeleton market in the U.S. is estimated at US$435.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$914.1 Million by the year 2030 trailing a CAGR of 21.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.6% and 19.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.4% CAGR.

Global Medical Exoskeleton Market - Key Trends and Drivers Summarized

How Are Medical Exoskeletons Redefining Mobility in Healthcare?

Medical exoskeletons are wearable devices that provide powered support to individuals with mobility impairments, such as those recovering from spinal cord injuries or suffering from conditions like multiple sclerosis or stroke. These devices assist users in walking, standing, and even performing rehabilitation exercises, greatly improving their quality of life. Medical exoskeletons are increasingly being adopted in rehabilitation centers and hospitals, where they are used to accelerate recovery and restore mobility. By offering enhanced physical assistance, exoskeletons are also enabling patients to achieve greater independence, reducing the burden on caregivers and healthcare professionals.

What Innovations Are Shaping the Medical Exoskeleton Market?

Innovations in medical exoskeletons include advancements in robotics, lightweight materials, and AI-driven motion control systems. These developments are enabling more intuitive and responsive exoskeletons, allowing for smoother and more natural movements. The integration of AI is helping exoskeletons learn from user movements and adjust in real-time, making them more effective for long-term rehabilitation. Additionally, exoskeletons are becoming lighter and more comfortable to wear, thanks to new materials such as carbon fiber and advanced polymers. Battery technology is also improving, allowing exoskeletons to be used for longer periods without the need for frequent recharging.

How Do Market Segments Define the Growth of Medical Exoskeletons?

Types include powered and passive exoskeletons, with powered exoskeletons accounting for the largest share due to their ability to provide greater mobility assistance. Applications range from rehabilitation to assistive devices for daily use, with rehabilitation being the primary segment as these devices are widely used in physical therapy. End-users include hospitals, rehabilitation centers, and home care settings, with hospitals and rehabilitation centers being the dominant sectors. Geographically, North America leads the market, followed by Europe, while Asia-Pacific is seeing rapid growth due to increasing investments in healthcare technology.

What Factors Are Driving the Growth in the Medical Exoskeleton Market?

The growth in the medical exoskeleton market is driven by several factors, including the increasing prevalence of neurological and mobility disorders, advancements in robotics and AI, and rising demand for rehabilitation technologies. As the global population ages, the incidence of mobility impairments is rising, driving demand for assistive technologies like exoskeletons. Advances in robotics and motion control systems are making these devices more effective and accessible, further boosting market growth. Additionally, the growing focus on improving patient outcomes through rehabilitation and the increasing availability of insurance coverage for medical exoskeletons are contributing to the market's expansion.

Select Competitors (Total 34 Featured) -

  • Bionik Laboratories Corp
  • B-TEMIA Inc.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • ExoAtlet
  • Gogoa Mobility Robots SL
  • Hocoma AG (A Subsidiary of DIH Technologies)
  • Parker Hannifin Corp
  • ReWalk Robotics Ltd
  • Rex Bionics Ltd.
  • Tyromotion GmbH
  • US Bionics
  • Wearable Robotics SRL

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Medical Exoskeleton - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Rehabilitation and Mobility Assistance Drives Growth in Medical Exoskeleton Market
    • Technological Advancements in Wearable Exoskeletons Strengthen Business Case for Adoption
    • Growing Focus on Improving Mobility in Patients with Disabilities Expands Addressable Market for Exoskeletons
    • Expansion of Medical Exoskeletons in Physical Therapy and Neurological Rehabilitation Fuels Market Growth
    • Increasing Adoption of Powered Exoskeletons for Spinal Cord Injury Patients Expands Market Opportunities
    • Technological Innovations in Lightweight and Battery-Powered Exoskeletons Propel Market Expansion
    • Rising Focus on Enhancing Patient Independence and Quality of Life Drives Demand for Medical Exoskeletons
    • Growing Use of Medical Exoskeletons in Stroke Recovery and Gait Training Expands Market Potential
    • Focus on Reducing Rehabilitation Time and Improving Therapy Outcomes Strengthens Demand for Exoskeletons
    • Rising Adoption of Medical Exoskeletons in Elderly Care and Assisted Living Facilities Expands Addressable Market
    • Technological Advancements in AI-Enabled and Smart Exoskeleton Systems Propel Market Growth
    • Rising Demand for Pediatric Exoskeletons for Mobility Assistance Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Medical Exoskeleton by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Medical Exoskeleton by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 3: World 18-Year Perspective for Medical Exoskeleton by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 6: World 18-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 9: World 18-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Powered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Powered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 12: World 18-Year Perspective for Powered by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 15: World 18-Year Perspective for Passive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 18: World 18-Year Perspective for Mobile by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Stationary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Stationary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 21: World 18-Year Perspective for Stationary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
    • TABLE 22: World Medical Exoskeleton Market Analysis of Annual Sales in US$ for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 25: USA 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 28: USA 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 31: USA 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 34: Canada 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 37: Canada 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 40: Canada 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • JAPAN
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 43: Japan 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 46: Japan 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 49: Japan 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • CHINA
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 52: China 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 55: China 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 58: China 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • EUROPE
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Medical Exoskeleton by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 61: Europe 18-Year Perspective for Medical Exoskeleton by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 64: Europe 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 67: Europe 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 70: Europe 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • FRANCE
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 73: France 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 76: France 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 79: France 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • GERMANY
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 82: Germany 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 85: Germany 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 88: Germany 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 91: Italy 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 94: Italy 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 97: Italy 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • UNITED KINGDOM
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 100: UK 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 103: UK 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 106: UK 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 112: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • ASIA-PACIFIC
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 121: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
  • REST OF WORLD
    • TABLE 125: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of World Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 127: Rest of World 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of World Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 130: Rest of World 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
    • TABLE 133: Rest of World 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030

IV. COMPETITION